Activating p53Y220C with a Mutant-Specific Small Molecule
Zhu, X.; Byun, W. S.; Pienkowska, D. E.; Nguyen, K. T.; Gerhartz, J.; Geng, Q.; Qiu, T.; Zhong, J.; Jiang, Z.; Wang, M.; Sarott, R. C.; Hinshaw, S. M.; Zhang, T.; Attardi, L. D.; Nowak, R. P.; Gray, N. S.
Show abstract
TP53 is the most commonly mutated gene in cancer, but it remains recalcitrant to clinically meaningful therapeutic reactivation. We present here the discovery and characterization of a small molecule chemical inducer of proximity that activates mutant p53. We named this compound TRanscriptional Activator of p53 (TRAP-1) due to its ability to engage mutant p53 and BRD4 in a ternary complex, which potently activates mutant p53 and triggers robust p53 target gene transcription. Treatment of p53Y220C expressing pancreatic cell lines with TRAP-1 results in rapid upregulation of p21 and other p53 target genes and inhibits the growth of p53Y220C-expressing cell lines. Negative control compounds that are unable to form a ternary complex do not have these effects, demonstrating the necessity of chemically induced proximity for the observed pharmacology. This approach to activating mutant p53 highlights how chemically induced proximity can be used to restore the functions of tumor suppressor proteins that have been inactivated by mutation in cancer.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure-aided development of small molecule inhibitors of ENPP1, the extracellular phosphodiesterase of the immunotransmitter cGAMP 95%
- Piperlongumine (PL) conjugates induce targeted protein degradation 95%
- Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis 95%
Similar papers in this journal
- Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity. 95%
- Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog Pathway Inhibitor-1 95%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 94%
Similar papers in this journal
- Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC 94%
- Machine learning-augmented molecular dynamics simulations (MD) reveal insights into the disconnect between affinity and activation of ZTPriboswitch ligands 94%
- Molecular basis for two stereoselective Diels-Alderases that produce decalin skeletons 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.